What is PCSA stock price today?

Visit our real-time dashboard for the current PCSA stock price and live market data.

Is PCSA stock going up or down today?

PCSA stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy PCSA stock now?

The decision to buy PCSA depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is PCSA a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for PCSA based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is PCSA stock overvalued or undervalued?

Use our DCF valuation calculator to determine if PCSA is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is PCSA's P/E ratio?

P/E ratio data for PCSA will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is PCSA's market cap?

PCSA (Processa Pharmaceuticals Inc) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is PCSA's price to book ratio?

PCSA trades at a price-to-book (P/B) ratio of 2.27, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does PCSA pay dividends?

PCSA does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is PCSA's dividend yield?

PCSA does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is PCSA stock a good long-term investment?

PCSA's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is PCSA's revenue growth rate?

Revenue growth data for PCSA is available on our dashboard with detailed financial statement analysis.

Profitability metrics for PCSA are available on our dashboard with complete income statement analysis.

What are the risks of investing in PCSA?

Key risks for PCSA include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does PCSA compare to its competitors?

Compare PCSA to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize PCSA's performance and positioning.

What is PCSA's stock price target for 2026?

Visit our prediction page for AI-powered price targets for PCSA with bull, base, and bear case scenarios.

What do analysts say about PCSA?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for PCSA. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is PCSA's next earnings report?

PCSA reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

PCSA - Processa Pharmaceuticals Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Processa Pharmaceuticals Inc

Processa Pharmaceuticals Inc (PCSA) common stock

Price Chart

Loading chart...

PCSA Key Statistics

Market Cap

$5.91M

P/B Ratio

2.27

How PCSA Compares to Peers

PCSA is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
PCSA(This stock)	$5.91M	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 17, 2026 at 9:05 AM EDT

Ready to invest in PCSA?

Commission-free trading available. Affiliate links.

PCSA Lician Score

5% confidence

4.0/10

Neutral

PCSA has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates PCSAacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

PCSA Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for PCSA

Dashboard

Enter a ticker to analyze